Skip to main content
. 2018 Jan 11;13(1):e0191093. doi: 10.1371/journal.pone.0191093

Table 1. Characteristics of the included studies in alphabetical order.

Primary Studies GD FS AS NW WS WD MW MP MA PC NT
[42] Abegão 2015 SA NFS RL 12 50.2 FT Punch DS - NR 2
Brazil (rabbit)
[43] Al-Bayati 2013 AS NS NRL 40 900.0 FT Blade DS CaCl2 < 1
Iraq (goat)
[44] Barrionuevo 2015 SA NFS RL 12 50.2 FT Punch DS CG NR 1
Brazil (rabbit)
[45] Bauer 2009 SA NS RL 8 19.6 FT 2mm Punch SS CaCl2 < 1
Brazil (rat)
[46] Blanton 2009 NA P NRL 48 150.0 FT 7.9mm Blade SS T/TP
CaCl2
< 1
USA (pig) ep,de,sc
[47] De Souza 2015 SA NP NRL 28 625.0 FT Blade DS - < 1
Brazil (horse) ep,de,sc
[48] Dionyssiou 2013 EU P RL 40 400.0 FT Blade SS - 1
Greece (rabbit)
[49] Hadad 2010 NA P NRL 36 150.0 FT 4mm - SS T/TP
CaCl2
< 1
USA (pig)
[50] Jee 2016 AS NS NRL 24 28.3 FT Punch SS - 2
Korea (dog) ep,de
[51] Karayannop. 2015 EU P NRL 36 400.0 FT - SS - 1
Greece (dog)
[52] Lee 2008 NA NP RL 30 625.0 FT Blade SS T/TP
CaCl2
NR 1
USA (rabbit) ep,de,sc
[53] Monteiro 2009 EU NP NRL 24 625.0 FT Blade SS T/TP
CaCl2
NR 2
France (horse) ep,de,sc
[54] Nisbet 2009 AS NS RL 30 225.0 FT Blade DS T/TP
CaCl2
2
Turkey (rabbit) ep,de,sc
[55] Notodihardjo 2014 AS NP RL 180 28.3 FT Punch DS CaCl2 1
Japan (mouse) ep,de,sc
[30] Sardari 2011 AS NP NRL 30 400.0 FT - DS T/TP
CaCl2
< 2
Iran (dog)
[56] Vermeulen 2009 EU NS NRL 21 400.0 FT 1cm Blade DS T NR 1
Belgium (pig) ep,de,sc
[57] Yan 2007 NA P NRL 48 226.9 FT 5mm Punch DS T/TP
CaCl2
NR 1
USA (pig)
[58] Yang 2011 Asia NP RL 14 400.0 FT Scissor DS - NR 1
Korea (mouse) ep,de,sc

GD: Geographical distribution; SA: SouthAmerica; NA: NorthAmerica; EU: Europe; AS: Asia; FS: Funding source; P: for profit funding; NP: for non-profit funding; NFS: no-funding statement; NS: no statement regarding the funding source; AS: Animal species; RL: rodent/lagomorph mammals; NRL: non-rodent/lagomorph mammals; NW: Number of wounds; WS: Initial wound size (mm2); WD: Wound depth; FT: full-thickness; ep: epidermidis; de: dermis; sc: subcutaneous tissue; MW: Method of wounding; MP: Method of PRP production; SS: single spin; DS: double spin; MA: Method of PRP Activation; CG: Calcium Gluconate; T: Thrombin; TP: Thromboplastin; PC: Platelet concentration; <: platelet concentration < 106 plt/microL; ≥: platelet concentration ≥ 106 plt/microL; NR: not reported. NT: Number of treatments